Evidence map›Paper›PMID 18386033›Full record

ArticleInternational journal of legal medicine2008

An epidemic of fatal 3-methylfentanyl poisoning in Estonia.

Ilkka Ojanperä, Merja Gergov, Milana Liiv, Aime Riikoja, Erkki Vuori

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of legal medicine, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 63 citations in OpenAlex.

  1. Article
  2. Blood concentrations of new synthetic opioids.International journal of legal medicine · 2022
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Fatalities caused by novel opioids: a review.Forensic sciences research · 2019
    Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ilkka OjanperäDepartment of Forensic Medicine, University of Helsinki, P.O. Box 40, 00014, Helsinki, Finland. ilkka.ojanpera@helsinki.fi.
Merja Gergov
Milana Liiv
Aime Riikoja
Erkki Vuori
University of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An exceptional epidemic of poisonings due to the highly potent opioid designer drug 3-methylfentanyl (TMF) was revealed among Estonian drug users in 2005-2006 by post-mortem forensic toxicology. Quantitative analysis of cis-TMF, trans-TMF, and fentanyl was performed by liquid chromatography-tandem mass spectrometry. Comprehensive toxicological analysis was performed using a multi-technique approach. The number of TMF-related fatal accidental poisonings identified was 46 and 71 for 2005 and 2006, respectively. The proportion of male victims was 91.5% and the mean age of all victims was 26 years at death. TMF was used predominantly by intravenous injection. There was no significant difference in the blood concentrations of cis-TMF and trans-TMF between pure TMF poisonings and mixed TMF poisonings. The mean combined concentration of TMF stereoisomers among pure TMF cases (1.9 microg/l) was more than ten times lower than the mean fentanyl concentration in fentanyl-related fatalities. Concomitant use of other drugs involved alcohol, amphetamines, benzodiazepines, and cannabis, but very rarely other opioids.

Indexed as

AdultAnalgesicsChromatography, LiquidDisease OutbreaksEstoniaFemaleFentanylForensic ToxicologyHumansMaleMolecular StructurePoisoningSex DistributionStereoisomerismSubstance-Related DisordersTandem Mass Spectrometry3-methylfentanylAnalgesicsFentanyl

Identifiers

PMID18386033
OpenAlexW2016855037

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.